Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets

Fei Jiang; Yanlong Shi; Yue Wang; Chang Ge; Jun Zhu; Hanlu Fang; Yu Zhang; Yixiao Zhang; Haokun Jian; Tong Lei; Sheng Lan; Liyu Cao; Hongzhu Yu; Debao Fang

doi:doi:10.18632/aging.204591

← Back

Research Paper Volume 15, Issue 6 pp 2066—2081

Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets

Figure 5. Analysis of immunologic molecular, TMB, and MSI of SHCBP1 expression in pan-cancer. (A) Correlation between 33 kinds of inhibitory, stimulatory and SHCBP1 expression. (B) Correlation between TMB and SHCBP1 expression. (C) Correlation between MSI and SHCBP1 expression. *P<0.05; **P<0.01; ***P<0.001.